Skip to main content

Table 3 Guidance related to perspective, comparator/base case, options for appraisal, time horizon and discount rate

From: A cost–benefit analysis framework for preventive health interventions to aid decision-making in Australian governments

Document title

Perspective and referent group

Comparator/base case

Options for appraisal, (number and specifications)

Time horizon

Discount rate theoretical foundation and value for primary analysis (range for sensitivity analyses)

Cost–benefit analysis guidance note (2020) [33]

Societal: impacts on all Australian residents

Business as usual, do nothing

 ≥ 3; 1 non-regulatory option

Life of policy; 10 years for regulatory costs [85]

Opportunity cost of capital: 7% (3% and 10%)

Handbook of Cost–Benefit Analysis January (2006) [45]

Societal

Business as usual, do nothing

Not specified

Life of policy

Opportunity cost of capital: no values given

Assessment framework: for initiatives and projects to be included in the Infrastructure Priority List (2018) [48]

Societal: Australian community

Do minimum

Step 1: high-level MCA on long list of options. Step 2: rapid CBA on short list and more detailed MCA. Step 3: detailed CBA on final short list (≥ 2 options)

Life of asset. Duration needs to be justified

Theory not stated: 7% (4% and 10%)

Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (2016) [31]

Healthcare system

Optional: Societal

Existing technology/clinical practice replaced by the proposed medicine

Proposed new medicine

Duration to capture all important differences in costs and benefits between intervention and comparator

Theory not stated: 5% (0% & 3.5%)

NSW Government Guide to Cost–Benefit Analysis (2017) [4]

Societal: NSW community

Business as usual, no policy change, status quo

Full range of realistic options; variations in scale and scope, targeting supply and demand, alternative implementation plans

Life of policy/asset; 20–30 years

Opportunity cost of capital: 7% (3% and 10%)

Transport for NSW Cost–Benefit Analysis Guide (2019) [8]

Cites NSW Treasury guidance [4]: Societal: NSW community

Business as usual, do minimum

 ≥ 3 for large projects and ≥ 2 for smaller projects

Life of asset. Cites NSW Treasury guidance [4] (30 years). No longer than 50 years

Social rate of time preference: cites NSW Treasury guidance [4]: 7% (3% and 10%)

Guidelines for using cost–benefit analysis to assess coastal management options (2018) [7]

Societal: LGA community

Continuation of current management, business as usual

Number not specified. Options should be discrete and not reliant on other options. Variations in options treated as individual options

Life of project. Cites NSW Treasury guidance [4] (30 years). Longer time horizons can be adopted (e.g. 50 years)

Theory not stated: cites NSW Treasury guidance [4]; however, lower value differs: 7% (4% and 10%)

Guide to Cost–Benefit Analysis of Health Capital Projects (2018) [37]

Cites NSW Treasury guidance [4]: Societal: NSW community

Status quo, keep safe and operating

Step 1: high-level CBA on long list of options. Stage 2: detailed CBA on short list (≥ 2 options)

Practical asset life; 20–30 years

Cites NSW Treasury guidance [4]: 7% (3% and 10%)

Commissioning Economic Evaluations: A Guide (2017) [49]

Health sector

Optional: whole of government, societal

Current practice

Not specified (focus of guidance on ex-post evaluations)

Length of time over which outcomes are likely to accrue

Reports recommended rates vary by jurisdiction. Cites NSW Treasury guidance [4]; however, a recommended rate not stated

  1. CBA cost–benefit analysis, LGA local government area, MCA multi-criteria analysis, NSW New South Wales, OBPR Office of Best Practice Regulation, PM&C Prime Minister and Cabinet